Sale!

STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test is a specialized diagnostic tool designed to identify mutations in the STAR gene, which are responsible for a rare form of congenital adrenal hyperplasia (CAH) known as Lipoid CAH. This condition impairs the body’s ability to produce vital hormones, leading to severe electrolyte imbalances, genital abnormalities in females, and potentially life-threatening adrenal crises. The test, available at DNA Labs UAE, involves analyzing the patient’s DNA to detect any genetic abnormalities in the STAR gene, providing crucial information for accurate diagnosis, management, and genetic counseling. The cost of the test is 4400 AED, a worthwhile investment for families seeking clarity on this rare genetic condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Genetic Lab Blog – STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test

Welcome to the DNA Labs UAE blog! In this article, we will discuss the STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test, its cost, symptoms, diagnosis, and more. If you or your loved ones are affected by this condition, this test can provide valuable information about the specific genetic variant causing the condition and guide treatment decisions.

Test Name: STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hepatology, Nephrology, Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for STAR Gene Lipoid Congenital Adrenal Hyperplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with STAR Gene Lipoid Congenital Adrenal Hyperplasia NGS Genetic DNA Test gene STAR

Test Details

Lipoid congenital adrenal hyperplasia (LCAH) is a rare autosomal recessive disorder characterized by a deficiency in the steroidogenic acute regulatory protein (StAR). StAR is responsible for transporting cholesterol into the mitochondria, where it is converted into steroid hormones, including cortisol and aldosterone.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. It can be used to identify genetic variations, such as mutations or deletions, in the genes associated with LCAH, including the STAR gene. The STAR gene is located on chromosome 8 and encodes the StAR protein. Mutations in the STAR gene can lead to impaired cholesterol transport, resulting in a deficiency of cortisol and aldosterone production and an accumulation of cholesterol in the adrenal glands.

NGS genetic testing for LCAH involves sequencing the coding regions of the STAR gene to identify any potential disease-causing mutations. This can help confirm a diagnosis of LCAH and provide information about the specific genetic variant causing the condition.

Genetic testing for LCAH can be useful in confirming a diagnosis, predicting disease severity, guiding treatment decisions, and providing genetic counseling for affected individuals and their families. It can also help with prenatal testing and family planning for individuals at risk of passing on the condition.

It is important to note that NGS genetic testing for LCAH should be performed by a qualified genetic testing laboratory and interpreted by a healthcare professional with expertise in genetic disorders. The results of genetic testing should be considered in conjunction with other clinical and laboratory findings to make a comprehensive diagnosis and management plan.

At DNA Labs UAE, we offer the STAR Gene Lipoid Congenital Adrenal Hyperplasia Genetic Test at a cost of 4400.0 AED. Our state-of-the-art NGS technology and experienced team ensure accurate and reliable results. Contact us today to schedule your test and gain valuable insights into your genetic health.

Test Name STAR Gene Lipoid congenital adrenal hyperplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for STAR Gene Lipoid congenital adrenal hyperplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with STAR Gene Lipoid congenital adrenal hyperplasia NGS Genetic DNA Test gene STAR
Test Details

Lipoid congenital adrenal hyperplasia (LCAH) is a rare autosomal recessive disorder characterized by a deficiency in the steroidogenic acute regulatory protein (StAR). StAR is responsible for transporting cholesterol into the mitochondria, where it is converted into steroid hormones, including cortisol and aldosterone.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. It can be used to identify genetic variations, such as mutations or deletions, in the genes associated with LCAH, including the STAR gene.

The STAR gene is located on chromosome 8 and encodes the StAR protein. Mutations in the STAR gene can lead to impaired cholesterol transport, resulting in a deficiency of cortisol and aldosterone production and an accumulation of cholesterol in the adrenal glands.

NGS genetic testing for LCAH involves sequencing the coding regions of the STAR gene to identify any potential disease-causing mutations. This can help confirm a diagnosis of LCAH and provide information about the specific genetic variant causing the condition.

Genetic testing for LCAH can be useful in confirming a diagnosis, predicting disease severity, guiding treatment decisions, and providing genetic counseling for affected individuals and their families. It can also help with prenatal testing and family planning for individuals at risk of passing on the condition.

It is important to note that NGS genetic testing for LCAH should be performed by a qualified genetic testing laboratory and interpreted by a healthcare professional with expertise in genetic disorders. The results of genetic testing should be considered in conjunction with other clinical and laboratory findings to make a comprehensive diagnosis and management plan.